Doxazosin hydrochloride

BGC Id:	151242506159
CAS No:	70918-01-3
Synonyms:	1-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazinehcl ; 1-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazinehydrochloride ; doxazosin hydrochloride ; 1-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazine hydrochloride
Molecular Formula:	C23H25N5O5.HCl
Molecular Weight:	487.94
EINECS:

Verified providers in 2025

The following notable provider has been checked and can be recommended.

BuGuCh & Partners

Type de compagnie: Producer

pays: Germany

We, BuGuCh & Partners, are an international acting and innovative company, leading in developing and manufacturing. We operates major facilities in North America, Europe and the Pacific Rim, as well as facilities in China, Japan and Saudi Arabia operated through joint ventures. We maintain independently or are partners of some production site ...

INQUIRY | ORDER

What other providers are available for CAS 70918-01-3?

The last intensive check and update was carried out on 2025/05/30.

Identify

Synonyms:

1-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazinehcl ; 1-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazinehydrochloride ; doxazosin hydrochloride ; 1-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazine hydrochloride

CAS:

70918-01-3

EINECS:

Molecular Formula:

C23H25N5O5.HCl

MDL:

Properties

Molecular Weight:

487.94 g·mol−1

What other providers are available for CAS 70918-01-3?

In addition to the providers presented here for Doxazosin hydrochloride with the CAS number 70918-01-3, there are other 3 providers with slightly different product names available for this CAS number.

1-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazine hydrochloride

BuGuCh & Partners +2 additional providers that we know from the past